October 14, 2020


1:00 PM – 4:00 PM ET


The Sentinel Initiative, an active medical product surveillance system, was established in response to the Food and Drug Administration (FDA) Amendments Act of 2007 and has become one of the Agency’s premier evidence generation platforms. The 12th Annual Sentinel Initiative Public Workshop is being convened virtually on October 14, 2020 by the Robert J. Margolis, MD, Center for Health Policy under a cooperative agreement with the FDA.

12th Annual Sentinel Initiative Public Workshop
Wednesday October 14, 2020; 1:00 pm to 4:00 pm

The Food and Drug Administration (FDA), under cooperative agreement with the Robert J. Margolis, MD, Center for Health Policy at Duke University, is hosting the 12th annual Sentinel Initiative public workshop virtually on October 14, 2020. The annual workshop is a gathering of the Sentinel community and leading experts to share recent developments within the Sentinel Initiative, provide training on the Sentinel system’s tools and data infrastructure, and promote engagement and collaboration with patients, industry and consumers.
The virtual public workshop will highlight recent achievements and strategic initiatives underway to enhance and build a more robust Sentinel Initiative and stakeholders will discuss opportunities to advance Sentinel’s existing data, infrastructure, and technology.

Further information about the events and registration is available at: